Oragenics Project to Develop a Variant-Agnostic Protein Antigen for Use in its COVID-19 Intranasal Vaccine Receives Funding from CQDM

vaccine - Trending on BuzzSumo 2023-06-05

Summary:

Oragenics Project to Develop a Variant-Agnostic Protein Antigen for Use in its COVID-19 Intranasal Vaccine Receives Funding from CQDM healthstockshub.com

Link:

https://healthstockshub.com/news/nyseamex/ogen/oragenics-project-to-develop-a-variant-agnostic-protein-antigen-for-use-in-its-covid-19-intranasal-vaccine-receives-funding-from-cqdm

From feeds:

Tags:

all_vaccine

Date tagged:

06/05/2023, 17:15

Date published:

06/05/2023, 16:59